Page 94 - 南京医科大学学报自然科学版

第43卷第7期
·980 · 南 京 医 科 大 学 学 报 2023年7月

+
loidentical allogeneic hematopoietic stem cell transplanta⁃ comes than CD34 cell number in reduced⁃intensity mobi⁃
tion for acute myeloid leukemia using peripheral blood lized peripheral blood allogeneic hematopoietic cell trans⁃
stem cells. A study from the acute leukemia working Party plantation［J］. Haematologica，2016，101（4）：499-505
of the European Society for blood and marrow transplanta⁃ ［12］ SALAS M Q，ATENAFU E G，BAUTISTA M R，et al. Im⁃
+
tion（EBMT）［J］. Am J Hematol，2020，95（8）：892-899 pact of CD34 cell dose on reduced intensity conditioning
［7］ CAO L Q，XU L P，ZHANG X H，et al. Relationship of regimen haploidentical hematopoietic stem cell transplan⁃
cell compositions in allografts with outcomes after haploi⁃ tation［J］. Eur J Haematol，2020，104（1）：36-45
+
dentical transplantation for acquired severe aplastic ane⁃ ［13］ ELMARIAH H，NAQVI S M H，KIM J，et al. CD34 cell
mia：effects of CD34（+）and CD14（+）cell doses［J］. dose influences survival after allogeneic peripheral blood
Chin Med J（Engl），2018，131（18）：2185-2192 stem cell transplantation with post-transplant cyclophos⁃
［8］ PATEL S S，RYBICKI L A，CORRIGAN D，et al. Effect phamide［J］. Blood，2019，134（Supplement1）：3329
+
of bone marrow CD34 cells and T⁃cell subsets on clinical ［14］ KRÖGER N. Preventing graft⁃versus⁃host disease without
outcomes after myeloablative allogeneic hematopoietic losing graft⁃versus⁃leukemia effect after allogeneic stem⁃
cell transplantation［J］. Bone Marrow Transplant，2019， cell transplantation［J］. J Clin Oncol，2020，38（29）：
54（5）：775-781 3357-3360
［9］ TANG F F，SUN Y Q，MO X D，et al. Incidence，risk fac⁃ ［15］ SALIBA R M，VELTRI L，RONDON G，et al. Impact of
tors，and outcomes of primary prolonged isolated thrombo⁃ graft composition on outcomes of haploidentical bone mar⁃
cytopenia after haploidentical hematopoietic stem cell row stem cell transplantation［J］. Haematologica，2021，
transplant［J］. Biol Blood Marrow Transplant，2020，26 106（1）：269-274
（8）：1452-1458 ［16］ RANTI J H，KURKI S，SALMENNIEMI U，et al. Early
+
［10］ IKEGAWA S，MATSUOKA K I. Harnessing Treg homeo⁃ CD8 ⁃recovery independently predicts low probability of
stasis to optimize posttransplant immunity：current con⁃ disease relapse but also associates with severe GVHD af⁃
cepts and future perspectives［J］. Front Immunol，2021， ter allogeneic HSCT［J］. PLoS One，2018，13（9）：

12：713358 e0204136
［11］ MARTIN P S，LI S，NIKIFOROW S，et al. Infused total ［收稿日期］ 2022-10-08
nucleated cell dose is a better predictor of transplant out⁃ （责任编辑：蒋 莉）